By Chuck Mikolajczak
NEW YORK (Reuters) - U.S. stocks were little changed on Tuesday as investors found few reasons to push the S&P 500 above its recent record high, as tensions in Ukraine continued.
Despite setting a record high on March 7, the S&P 500 has been range-bound over the last few sessions, amid a dearth of corporate earnings or data-related incentives to push equities higher.
"The market has growing pains here, and rightfully so," said Peter Cardillo, chief market economist at Rockwell Global Capital in New York.
"Basically we are at high levels, there are a lot of warnings out there, a lot of signs the market may be topping out."
Investors were also wary in light of events in Ukraine. A pro-Russian force opened fire in seizing a Ukrainian military base in Crimea on Monday and NATO announced reconnaissance flights along its eastern frontiers as confrontation around the Black Sea peninsula showed no sign of easing.
On Tuesday, ousted leader Viktor Yanukovich insisted he remained Ukraine's legitimate president and commander-in-chief, saying he would return to Kiev and appealing to the armed forces to defy any "criminal orders" handed down by his foes.
The Dow Jones industrial average rose 15.42 points, or 0.09 percent, to 16,434.1, the S&P 500 gained 1.91 points, or 0.1 percent, to 1,879.08 and the Nasdaq Composite added 12.958 points, or 0.3 percent, to 4,347.405.
U.S. wholesale inventories rose 0.6 percent in January, more than the 0.4 percent expected, as companies built up stocks of autos and machinery, though sales posted their largest decline in nearly five years.
J.C. Penney Co Inc jumped 8.3 percent to $9.12 after Citigroup raised the stock to a "buy" and boosted its price target to $11 per share.
Urban Outfitters Inc dropped 5 percent to $35.63 as the worst performer on the S&P 500 after it reported lower-than-expected quarterly sales, citing winter weather, and said it was "very cautious" on its current-quarter performance.
The S&P retail index slipped 0.1 percent.
American Eagle Outfitters Inc slumped 6 percent to $13.36 after the teen apparel retailer reported fourth-quarter earnings and forecast earnings for the current quarter that were short of expectations.
Dick's Sporting Goods Inc advanced 2 percent to $55.40 after the company posted fourth-quarter earnings and gave its first-quarter outlook.
Myriad Genetics Inc lost 9.4 percent to $34.19 after the diagnostics company said a U.S. court denied a motion that would have stopped rival Ambry Genetics Corp from selling a similar version of Myriad's cancer test.
La Jolla Pharmaceutical Co surged 61 percent to $17.55 after the company said its lead experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study.
(Editing by Bernadette Baum)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
